Spyre Therapeutics, Inc. earnings per share and revenue

SYRE earnings per share for the last quarter are -1.36 USD whereas the estimation was -0.82 USD which accounts for -64.98% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.05 USD, and revenue is expected to reach 4.20 M USD. Also watch annual changes over time to get a bigger picture of SYRE earnings per share and revenue dynamics.